Ngā hua rapu kaituhi :: APM

1

Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy mā Suangson Supabphol, Lijin Li, S. Peter Goedegebuure, William E. Gillanders

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Cross-dressed CD8α <sup>+</sup> /CD103 <sup>+</sup> dendritic cells prime CD8 <sup>+</sup> T cells following vaccination mā Lijin Li, Sojung Kim, John M. Herndon, Peter S. Goedegebuure, Brian A. Belt, Ansuman T. Satpathy, Timothy P. Fleming, Ted H. Hansen, Kenneth M. Murphy, William E. Gillanders

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer mā Venkataswarup Tiriveedhi, Natalia Tucker, John M. Herndon, Lijin Li, Mark Sturmoski, Matthew J. Ellis, X. Cynthia, Michael Naughton, A. Craig Lockhart, Feng Gao, Timothy P. Fleming, Peter S. Goedegebuure, Thalachallour Mohanakumar, William E. Gillanders

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity mā Stephen T. Ferris, Vivek Durai, Renee Wu, Derek J. Theisen, Jeffrey P. Ward, Michael D. Bern, Jesse T. Davidson, Prachi Bagadia, Tiantian Liu, Carlos G. Briseño, Lijin Li, William E. Gillanders, Gregory F. Wu, Wayne M. Yokoyama, Theresa L. Murphy, Robert D. Schreiber, Kenneth M. Murphy

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation mā Lijin Li, Xiuli Zhang, Xiaoli Wang, Samuel W. Kim, John M. Herndon, Michelle Becker‐Hapak, Beatriz M. Carreno, Nancy B. Myers, Mark Sturmoski, Michael D. McLellan, Christopher A. Miller, Tanner M. Johanns, Benjamin Tan, Gavin P. Dunn, Timothy P. Fleming, Ted H. Hansen, S. Peter Goedegebuure, William E. Gillanders

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity mā Xiuli Zhang, Samuel Kim, Jasreet Hundal, John M. Herndon, Shunqiang Li, Allegra A. Petti, Savas D. Soysal, Lijin Li, Michael D. McLellan, Jeremy Hoog, Tina Primeau, Nancy B. Myers, Tammi L. Vickery, Mark Sturmoski, Ian S. Hagemann, Chris Miller, Matthew J. Ellis, Elaine R. Mardis, Ted H. Hansen, Timothy P. Fleming, S. Peter Goedegebuure, William E. Gillanders

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients mā Xiuli Zhang, S. Peter Goedegebuure, Michael Y. Chen, Rashmi Mishra, Felicia Zhang, Yafei Yu, Kartik Singhal, Lijin Li, Feng Gao, Nancy B. Myers, Tammi L. Vickery, Jasreet Hundal, Michael D. McLellan, Mark Sturmoski, Samuel W. Kim, Ina Chen, Jesse T. Davidson, Narendra V. Sankpal, Stephanie Myles, Rama Suresh, X. Cynthia, Ademuyiwa Foluso, Andrea Wang‐Gillam, Sherri R. Davies, Ian S. Hagemann, Elaine R. Mardis, Obi L. Griffith, Malachi Griffith, Chris Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: